1992
DOI: 10.1083/jcb.118.6.1347
|View full text |Cite
|
Sign up to set email alerts
|

Pathways of internalization of the hCG/LH receptor: immunoelectron microscopic studies in Leydig cells and transfected L-cells.

Abstract: Abstract. Monoclonal anti-receptor antibodies were used to study the cellular traffic of the hCG/LH receptor by immunoelectron microscopy. The LHR38 antibody was shown to bind to the extraceUular domain of the receptor but not to interfere with hormone binding, adenylate cyclase activation or with the rate of internalization of the receptor. Pig Leydig cells and a permanent L-cell line expressing the LH receptor were used for the study. Incubation with LHR38-gold complexes showed the LH receptors to be randoml… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
66
0

Year Published

1994
1994
2003
2003

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(67 citation statements)
references
References 49 publications
1
66
0
Order By: Relevance
“…Thus, it is now known that the complex formed by the rat, mouse, or porcine LHR and one of its agonists (hCG) is internalized via clathrincoated pits (53) by a pathway that requires the involvement of a non-visual arrestin and dynamin (29,51). The rodent or porcine LHR⅐hCG complex is resistant to dissociation by the mild acidic pH that prevails in the endosomes (50), and a substantial proportion of the internalized complex is routed to the lysosomes where it dissociates prior to degradation (50,(52)(53)(54). By promoting the accumulation of the hCG⅐LHR complex in a compartment where it can be degraded, this pathway is ultimately responsible not only for the degradation of hCG (28) but also for a substantial loss of cell surface LHR that ensues following exposure of target or heterologous cells expressing the rodent or porcine LHR to agonists (13,36,55,56).…”
Section: Resultsmentioning
confidence: 99%
“…Thus, it is now known that the complex formed by the rat, mouse, or porcine LHR and one of its agonists (hCG) is internalized via clathrincoated pits (53) by a pathway that requires the involvement of a non-visual arrestin and dynamin (29,51). The rodent or porcine LHR⅐hCG complex is resistant to dissociation by the mild acidic pH that prevails in the endosomes (50), and a substantial proportion of the internalized complex is routed to the lysosomes where it dissociates prior to degradation (50,(52)(53)(54). By promoting the accumulation of the hCG⅐LHR complex in a compartment where it can be degraded, this pathway is ultimately responsible not only for the degradation of hCG (28) but also for a substantial loss of cell surface LHR that ensues following exposure of target or heterologous cells expressing the rodent or porcine LHR to agonists (13,36,55,56).…”
Section: Resultsmentioning
confidence: 99%
“…The sequence of a selected clone was verified and the plasmid was co-transfected with pRSV neo into human embryonic kidney (HEK 293) cells by the calcium phosphate precipitation method. Clonal cell lines expressing EE-Hm1 sites were selected in Dulbecco's modified Eagle's medium/H-16/F-12 with 10% fetal calf serum, 1% penicillin/streptomycin, and 400 mg/ml G418 in 5% CO 2 Receptor Binding Assay-Cells were seeded onto 12-well dishes, allowed to attach overnight, and then treated for specified times with 1 mM carbachol or buffer in incomplete medium at 37°C. Cells were placed on ice, washed three times with ice-cold PBS, and incubated with 1.5-2.0 nM [ 3 H]NMS at 12°C for 90 min.…”
Section: Methodsmentioning
confidence: 99%
“…An epitope tag with the sequence EYMPME was added to the aminoterminal of the receptor using the polymerase chain reaction. 2 The 5Ј primer with sequence TGAATTCACCATGGAATACATGCCAATG-GAAAACACTTCAGCCCCACCTGCTGTC was synthesized which contained the following components: an EcoRI restriction site, a 3Ј-nucleotide spacer, an initiating methionine, the sequence coding for the tag, and a portion of Hm1 sequence. The 3Ј primer with sequence TTG-GCGCCTGCTCGGTTCTCTGTCTCCCGGTA contained a BamHI restriction site.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This treatment did not change the rate of synthesis of the receptor (data not shown). Thus G s activation may modify the turn-over rate of the receptor, possibly by diverting some of the internalized receptor from the lysozymal degradation pathway (17) to the transcytotic pathway.…”
Section: Effect Of Brefeldin a And Effectors Of Trimeric G Proteins Omentioning
confidence: 99%